Wednesday, June 17, 2026

Finally -- A Glimmer Of Good News, On Bundibugyo: Moderna And Oxford mRNA Vaccine Candidate Trials To Begin In July 2026...


The only good news I can find about this '26 outbreak is that. . . one six month old, and his mother have recovered from the Bundibugyo / Ebola virus as of this week. That, and that Phase I clinical trial testing may begin on various mRNA Bundibugyo vaccine candidates -- in about two weeks.

All while the Africa CDC suspects that this outbreak may prove to eclipse the 12,000 deaths in 2012-14, before it is all over. But here is the encouraging news, just the same:

. . .NAIROBI/DAKAR, June 16 (Reuters) -- Lead vaccine candidates developed by Oxford University and Moderna against Ebola Bundibugyo, ⁠the deadly virus that has swept through eastern Democratic Republic of Congo, could enter Phase 1 trials as early ‌as ⁠July 1, with field trials possible within several months, the ⁠head of the Coalition for Epidemic Preparedness Innovations, ⁠Richard Hatchett, said on Tuesday. . . .


Excellent, indeed. Speed onward, you biological science-mavens -- we need your help desperately now in DRC and Uganda.

नमस्ते

No comments: